Perrigo Plc (PRGO) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Perrigo Company Plc  (NYSE: PRGO)


Perrigo Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRGO Gross Profit Margin (Jun 27 2026)
Q2 		(Mar 28 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 27 2025)
Q3 		(Jun 28 2025)
Q2
Y / Y Revenue Change -3.17 %
Seq. Revenue Change 5.61 %
Revenue In Millions $1,022.80
Gross Profit Margin 30.69 %
Gross Profit Margin Total Ranking # 2354
Gross Profit In Millions $313.90
Y / Y Gross Profit Change -13.5 %
Seq. Gross Profit Change -3.56 %


Commenting Second Quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 30.69 % due to increase in Cost of Sales and despite Revenue increase of 5.61 % to $1,023 millions.
Perrigo Company Plc achieved highest Gross Profit Margin in II. Quarter


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 127 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2354, from total ranking in the previous quarter at 2639.
Learn about Gross Margin
PRGO's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 128
Healthcare Sector # 371
Overall # 2335

Gross Profit Margin Statistics
High Average Low
43.11 % 36.43 % 30.69 %
(Sep 26 2015)   (Jun 27 2026)


PRGO Gross Income Trends • More of PRGO's Profitabilty Ratios • PRGO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PRGO's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PRGO's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PRGO's Competitors
Gross Profit Margin Profit Margin for Perrigo Plc's Suppliers
Gross Profit Margin Profit Margin for PRGO's Customers

You may also want to know
PRGO's Annual Growth Rates PRGO's Profitability Ratios PRGO's Asset Turnover Ratio PRGO's Dividend Growth
PRGO's Roe PRGO's Valuation Ratios PRGO's Financial Strength Ratios PRGO's Gross Profit Growth
PRGO's Roa PRGO's Inventory Turnover Ratio PRGO's Growth Rates PRGO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 27 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 27 2026 MRQ Gross ProfitJun 27 2026 MRQ Revenue
Renovorx Inc   84.27 %$ 0.766  Millions$ 0.909  Millions
Insmed Inc  84.20 %$ 358.274  Millions$ 425.486  Millions
Tg Therapeutics Inc   82.86 %$ 199.141  Millions$ 240.335  Millions
Evofem Biosciences Inc   80.59 %$ 2.122  Millions$ 2.633  Millions
Alkermes Plc   80.22 %$ 397.897  Millions$ 496.009  Millions
Phathom Pharmaceuticals Inc   79.68 %$ 59.178  Millions$ 74.274  Millions
Biomarin Pharmaceutical Inc  79.51 %$ 786.913  Millions$ 989.708  Millions
Akebia Therapeutics Inc   78.78 %$ 38.704  Millions$ 49.128  Millions
Lifevantage Corp  77.97 %$ 33.044  Millions$ 42.378  Millions
Puma Biotechnology Inc   77.92 %$ 44.027  Millions$ 56.502  Millions
Pacira Biosciences inc   77.05 %$ 148.235  Millions$ 192.399  Millions
Alnylam Pharmaceuticals Inc   76.90 %$ 992.687  Millions$ 1,290.948  Millions
Harmony Biosciences Holdings inc   75.81 %$ 198.082  Millions$ 261.280  Millions
Innoviva Inc   75.77 %$ 90.616  Millions$ 119.591  Millions
Tao Synergies Inc   75.11 %$ 0.067  Millions$ 0.089  Millions
Abbvie Inc   74.74 %$ 12,699.000  Millions$ 16,990.000  Millions
Nature s Sunshine Products inc   73.66 %$ 86.174  Millions$ 116.985  Millions
Merck and Co Inc   73.54 %$ 12,212.000  Millions$ 16,607.000  Millions
Pfizer Inc  72.78 %$ 10,942.000  Millions$ 15,034.000  Millions
Zoetis Inc   72.73 %$ 1,795.000  Millions$ 2,468.000  Millions
Bristol myers Squibb Company  71.28 %$ 9,247.000  Millions$ 12,973.000  Millions
Harrow Inc   71.27 %$ 50.363  Millions$ 70.661  Millions
Aquestive Therapeutics Inc   70.93 %$ 9.802  Millions$ 13.819  Millions
Earth Science Tech Inc   69.53 %$ 6.275  Millions$ 9.026  Millions
Omeros Corporation  69.37 %$ 27.731  Millions$ 39.976  Millions
Heron Therapeutics Inc   69.28 %$ 26.094  Millions$ 37.666  Millions
Johnson and Johnson  68.19 %$ 17,259.000  Millions$ 25,310.000  Millions
Evolus Inc   68.00 %$ 57.180  Millions$ 84.084  Millions
Eton Pharmaceuticals Inc   67.61 %$ 25.413  Millions$ 37.589  Millions
Fortress Biotech Inc   67.18 %$ 12.575  Millions$ 18.718  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.